9/3/2010

Allergan pleaded guilty to one misdemeanor charge and agreed to pay $600 million to settle criminal and civil charges regarding off-label marketing of Botox from 2000 to 2005. Botox was approved to treat only four medical conditions during that period.

Related Summaries